Upcoming Webinar: Recommendations for Multimodality Cardiovascular Imaging of Patients with HCM

Since the publication of the recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy (HCM) in 2011, an impressive growth and evolution of imaging techniques has occurred, enhancing both the recognition and management of the disease. Thus, an update was needed to provide recommendations that take into account these recent developments. Register for the Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy live webinar, scheduled for Thursday, July 28, from 6:00 – 7:00 PM ET on Zoom.

Lead author Sherif Nagueh, MD, FASE, will show how multimodality imaging plays a crucial role in the initial evaluation of patients with known or suspected HCM.

Learning Objectives:

  • Learn how to use multimodality imaging for patients with increased LV wall thickness
  • Demonstrate the assessment of dynamic obstruction, including provocable gradients and mitral valve anatomy
  • Implement multimodality imaging for risk stratification and prognostication
  • Use multimodality imaging for the assessment of ischemia and coronary artery disease

Attendees can earn 1.0 AMA PRA Category 1 Credit™ (pending approval) for attending this webinar. Registration for this webinar is FREE for ASE members (remember to login to your ASE Member portal) and costs $25 USD for nonmembers.